Breaking News: Embargoed Feed - hidden

Filters close
access_time Embargo lifts in 2 days
Embargo will expire: 1-Apr-2020 10:00 AM EDT Released to reporters: 27-Mar-2020 3:20 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 1-Apr-2020 10:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

access_time Embargo lifts in 2 days
Embargo will expire: 1-Apr-2020 4:00 PM EDT Released to reporters: 27-Mar-2020 2:20 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 1-Apr-2020 4:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

26-Mar-2020 2:35 PM EDT
COVID-19 linked to cardiac injury, worse outcomes for patients with underlying heart conditions
University of Texas Health Science Center at Houston

COVID-19 can have fatal consequences for people with underlying cardiovascular disease and cause cardiac injury even in patients without underlying heart conditions, according to a review published today in JAMA Cardiology by experts at The University of Texas Health Science Center at Houston (UTHealth).

access_time Embargo lifts in 2 days
Embargo will expire: 31-Mar-2020 5:00 PM EDT Released to reporters: 27-Mar-2020 10:55 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 31-Mar-2020 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

access_time Embargo lifts in 2 days
Embargo will expire: 31-Mar-2020 12:00 PM EDT Released to reporters: 27-Mar-2020 9:00 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 31-Mar-2020 12:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

access_time Embargo lifts in 2 days
Embargo will expire: 30-Mar-2020 12:05 AM EDT Released to reporters: 26-Mar-2020 7:10 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 30-Mar-2020 12:05 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

access_time Embargo lifts in 2 days
Embargo will expire: 30-Mar-2020 11:15 AM EDT Released to reporters: 26-Mar-2020 6:35 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 30-Mar-2020 11:15 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

24-Mar-2020 4:05 PM EDT
Insights From Ambulatory Blood Pressure Monitoring in Patients with Kidney Disease
American Society of Nephrology (ASN)

• Two studies examine potential benefits of blood pressure monitoring outside of doctors’ offices for patients with kidney disease.

access_time Embargo lifts in 2 days
Embargo will expire: 30-Mar-2020 11:00 AM EDT Released to reporters: 26-Mar-2020 4:50 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 30-Mar-2020 11:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

access_time Embargo lifts in 2 days
Embargo will expire: 1-Apr-2020 1:00 AM EDT Released to reporters: 26-Mar-2020 4:50 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 1-Apr-2020 1:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.


Showing results

110 of 10

close
2.78878